James Samuel Shannon - Director at Xilio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
XLO on Nasdaq
All Insider Reports
All Insider Reports

James Samuel Shannon - trading volume in the past year for Xilio Therapeutics, Inc.

Holdings reported by James Samuel Shannon for Xilio Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 70K $48.2K $0.69 Jun 17, 2025 Direct
Stock Option (right to buy) 31K Jun 11, 2025 Direct Common Stock

Transactions reported by James Samuel Shannon for Xilio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.